Join Dr. Marsha Rosner as she explores innovative strategies and novel approaches to tackle the challenges of metastatic triple-negative breast cancer, a particularly aggressive form of cancer affecting a diverse group of women.
Invasive breast cancer is a major cause of disease and death among women. In particular, triple-negative breast cancer (TNBC), a subtype of breast cancer that is clinically aggressive with high rates of metastasis and recurrence, disproportionately affects women of African descent and carriers of germline BRCA and PALB2 mutations. Amongst younger patients with breast cancer, the TNBC subtype was associated with higher pathologic stage and worse long-term survival. Although we have made major strides due to earlier diagnoses and targeted therapy, the mainstay of treatment for metastatic TNBC is chemotherapy and discovery of effective metastatic breast cancer treatments are needed.
In this webinar, Dr. Rosner will present some of the key challenges we face in trying to eliminate metastatic breast cancer. She will present different strategies for trying to effectively target metastatic disease and, based upon her work, some novel approaches to addressing these problems.
Key Topics Include:
- An understanding of the genetic and non-genetic drivers of metastatic breast cancer
- Explore the limitations of current approaches to treatment of metastatic breast cancer
- Consider other strategies for targeting breast cancer
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Charles B. Huggins Distinguished Service Professor
Ben May Department for Cancer Research
University of Chicago
Marsha Rich Rosner is the Charles B. Huggins Distinguished Service Professor at the University of Chicago. She was founder and first Chair of the graduate program in Cancer Biology and past Chair of the Ben May Department for Cancer Research. Among other honors, Dr. Rosner is a Fellow of the American Association for the Advancement of Science.
Additional Content From American Physiological Society
Engineering Neuromodulation for Cardiovascular Instability
Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
Skeletal Muscle Circadian Clocks: Keeping Time for Systemic Health
Dr. Karyn Esser presents the critical role of skeletal muscle circadian clocks in maintaining muscle strength, metabolic health, and systemic adaptations to endurance exercise.
Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station
Dr. Anne McArdle and Dr. Malcolm Jackson explore groundbreaking research from the Muscle Laboratories at the University of Liverpool. They examine how redox regulation influences the adaptive responses of skeletal muscle during physical activity and how these processes evolve with age.
Additional Content From Society for Women’s Health Research
Hypertension and Hypothalamic Changes in a Mouse Model of Menopause
Dr. Teresa Milner presents research using a mouse model of accelerated ovarian failure to explore estrogen's role in menopausal hypertension, highlighting the therapeutic potential of estrogen receptor beta agonists during menopause transition.
New Treatments for Vasomotor Symptoms Due to Menopause
Dr. JoAnn Pinkerton delves into the vasomotor symptoms associated with menopause, the current understanding of the physiological mechanisms involved, and the pharmacotherapies and treatments available.
Hormonal and Chromosomal Influences on Autoimmunity and Lupus
In this webinar, Drs. Betty Diamond and Melissa Cunningham present the historical and current understanding of hormonal and chromosomal influences on autoimmunity, highlighting B cell selection and activation.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Related Content
Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability
Join our webinar to discover how to de-risk ADC development through the integration of AI-driven analytics, mouse clinical trials and specialized translational models.
From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer
Learn how patient-derived organoids predict treatment response in metastatic colorectal cancer and explore findings from the OPTIC study on drug sensitivity and clinical outcomes.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.